Tag Archive for: Clinical trials

UK focuses on digital health research: £600m (US$764m) for new data platform according to the five recommendations of the Sudlow report.

Now approved in Europe: clinical trials for in vivo CAR T therapy. (Figure taken from Bui et al., in eBioMedicine 2024, CC BY NC ND 4.0, 
DOI: 10.1016/j.ebiom.2024.105266)

The Paul Ehrlich Institute (PEI) has approved expansion of the global INVISE Phase 1 clinical trial to Europe. The study aims to evaluate first-in-class gene therapy for the treatment of B-cell malignancies.

After meeting the primary endpoints of a pivotal Phase II trial, UK-based Adaptimmune Ltd. is submitting an FDA Biologics License Application for its autologous T-cell receptor therapy (TCR-T) Lete-cel (letetresgene autoleucel).

Prof. Dr Salah-Eddin Al-Batran Founder, Medical Director, Frankfurt Institute for Clinical Cancer Research IKF GmbH at the Northwest Hospital. Picture: © IKF GmbH

Over the past few years, the Frankfurt Institute of Clinical Cancer Research (IKF) has successfully conducted over 90 clinical studies. Each year, it enrolls approximately 1,500 patients in these trials. European Biotechnology spoke with the founder and director Prof. Dr med. Salah-Eddin Al-Batran.

Klineo team has grown since its inception in 2021. © Kineo SAS

Paris-based Klineo SAS has raised €2M to speed up access to clinical trials for oncology patients using an AI platform.
`

At the end of February, 200 German clinical trial experts gathered in Frankfurt/Main to discuss with representatives of the German Ministry of Health, how to implement model contract clauses into a law that speeds up clinical trials and translational medicine in Germany. According Model contract clauses have been established before by stakeholders from Deutsche Hochschulmedizin, das KKS-Netzwerk, die Pharmaverbände vfa und BPI sowie der CRO-Verband BVMA. © BVMA

With a new law, the German government wants to increase the number of clinical trials conducted in Germany and make the country number one in Europe again.

Ion Arocena; General Manager Asebio; © Asebio

Born with the aim of harmonising the application, evaluation, and supervision process of clinical trials conducted in EU countries, there is much room for improvement for the Clinical Trial Information System CTIS, particularly with regard to SMEs and translational researchers.

© crevis - stock.adobe.com

AVT03, a biosimilar candidate for osteoporosis treatment, showed promise in treating bone illnesses, according to results from a pharmacokinetic study by Alvotech SA.

Pictures: © MLM Medical Labs

Clinical trials have to be coordinated as a safe process where monitoring, analytics and handling of patient samples is streamlined – even cross oceans. German MLM Medical Labs is quickly establishing itself as an emerging central and specialty lab in the U.S.

Picture: ©BioLizard

Depending on who you talk to, artificial intelligence (AI) is either a saviour or an enslaver. The concerns range from loss of jobs through to robots running society. However, in the life sciences, the use of AI and machine learning (ML) have created some excitement over their potential applications.